Candida species: New insights into biofilm formation

Future Microbiology

Volumn 7, Issue 6, 2012, Pages 755-771

  Cuéllar Cruz, Mayra ^a   López Romero, Everardo ^b   Villagómez Castro, Julio C ^b   Ruiz Baca, Estela ^c  

^a INSTITUTO DERMATOLÓGICO DE JALISCO DR JOSÉ BARBA RUBIO   (Mexico)

^b UNIVERSITY OF GUANAJUATO   (Mexico)

^c UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

adhesins; ALS; biofilm; Candida species; cell wall; EPA; GPI proteins; mannoproteins; medical device; synchrotron light

Indexed keywords

ADHESIN; CALCIUM ION; MAGNESIUM ION; VIRULENCE FACTOR;

BIOFILM; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; FUNGUS GROWTH; HOSPITAL INFECTION; HOST CELL; HOST PATHOGEN INTERACTION; IMPLANT; MEDICAL DEVICE; NANOTECHNOLOGY; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYNCHROTRON RADIATION;

BIOFILMS; CANDIDA; CANDIDIASIS; CROSS INFECTION; EQUIPMENT AND SUPPLIES; HUMANS; VIRULENCE;

EID: 84862581014     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.48     Document Type: Review

References (175)

1. Cruz Ch R, Piontelli LE. Invasive fungal disease in patients from five hospitals in the Valparaiso region, Chile: 2004 to 2009. Rev. Chilena Infectol. 28(2), 123-129 (2011).
2. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev. 36(2), 288-305 (2011).
3. Bedini A, Venturelli C, Mussini C et al. Epidemiology of candidemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Clin. Microbiol. Infect. 12(1), 75-80 (2006). (Pubitemid 43372243)
4. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int. J. Antimicrob. Agents 38(1), 65-69 (2011).
5. Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int. J. Antimicrob. Agents 27(5), 359-366 (2006).
6. Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Alvarez C, Fernandez-Mazarrasa C, Farinas MC. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur. J. Clin. Microbiol. Infect. Dis. 22(4), 254-257 (2003). (Pubitemid 36578913)
7. Ben-Abraham R, Keller N, Teodorovitch N et al. Predictors of adverse outcome from candidal infection in a tertiary care hospital. J. Infect. 49(4), 317-323 (2004). (Pubitemid 39341778)
8. Garbino J, Kolarova L, Rohner P, Lew D, Pichna P, Pittet D. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 81(6), 425-433 (2002). (Pubitemid 35285962)
9. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 28(12), 1708-1717 (2002). (Pubitemid 35435471)
10. Garcia-San Miguel L, Cobo J, Martos I et al. Risk factors for candidemia in pediatric patients with congenital heart disease. Infect. Control Hosp. Epidemiol. 27(6), 576-580 (2006). (Pubitemid 44023392)
11. Marchetti O, Bille J, Fluckiger U et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin. Infect. Dis. 38(3), 311-320 (2004). (Pubitemid 38200105)
12. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20(1), 133-163 (2007). (Pubitemid 46167771)
13. Swinne D, Watelle M, Van der Flaes M, Nolard N. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study). Mycoses 47(5-6), 177-183 (2004). (Pubitemid 38903446)
14. Bassetti M, Righi E, Costa A et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6, 21 (2006).
15. Chakrabarti A, Chatterjee SS, Rao KL et al. Recent experience with fungaemia: change in species distribution and azole resistance. Scand. J. Infect. Dis. 41(4), 275-284 (2009).
16. Colombo AL, Guimaraes T, Silva LR et al. Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect. Control Hosp. Epidemiol. 28(5), 570-576 (2007). (Pubitemid 46814547)
17. Hagerty JA, Ortiz J, Reich D, Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg. Infect. (Larchmt) 4(3), 263-271 (2003). (Pubitemid 37428280)
18. Hasan F, Xess I, Wang X, Jain N, Fries BC. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect. 11(8-9), 753-761 (2009).
19. Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J. Med. Microbiol. 59(Pt 8), 873-880 (2010).
20. Samaranayake LP, Fidel PL, Naglik JR et al. Fungal infections associated with HIV infection. Oral Dis. 8(SUPPL. 2), 151-160 (2002). (Pubitemid 41758956)
21. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis. 35(5), 627-630 (2002).
22. Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin. Microbiol. Rev. 21(4), 606-625 (2008).
23. Duran MT, Velasco D, Canle D, Moure R, Villanueva R. Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001). Enferm. Infecc. Microbiol. Clin. 21(9), 488-492 (2003). (Pubitemid 37464309)
24. Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37(9), 1962-1965 (1993). (Pubitemid 23265560)
25. Cuellar-Cruz M, Villagomez-Castro JC, Ruiz-Baca E, Lopez-Romero E. Geographic distribution of Candida species and its correlation with blood type and biofilm formation. Curr. Trends Microbiol. 7, 61-86 (2011).
26. Colombo AL, Perfect J, DiNubile M et al. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 22(8), 470-474 (2003). (Pubitemid 37100593)
27. Pfaller MA, Diekema DJ, Jones RN et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. Clin. Microbiol. 39(9), 3254-3259 (2001). (Pubitemid 32830323)
28. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 19(5), 241-247 (2011).
29. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryot. Cell 4(4), 633-638 (2005). (Pubitemid 40600417)
30. Seider K, Heyken A, Luttich A, Miramon P, Hube B. Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape. Curr. Opin. Microbiol. 13(4), 392-400 (2010).
31. Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med. Mycol. 47(7), 681-689 (2009).
32. Borghi E, Sciota R, Biassoni C et al. Cell surface hydrophobicity: a predictor of biofilm production in Candida isolates?. J. Med. Microbiol. 60(Pt 5), 689-690 (2011).
33. Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat. Protoc. 3(12), 1909-1924 (2008).
34. Leonhard M, Reumuller A, Moser D, Bigenzahn W, Schneider-Stickler B. [Examination of biofilm related material deterioration on 20 PROVOX2 voice prostheses by scanning electron microscopy]. Laryngorhinootologie 88(6), 392-397 (2009).
35. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP. Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses 52(6), 467-475 (2009).
36. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183(18), 5385-5394 (2001). (Pubitemid 32802612)
37. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immunol. 322, 107-131 (2008).
38. Nobile CJ, Andes DR, Nett JE et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2(7), e63 (2006).
39. Nobile CJ, Mitchell AP. Genetics and genomics of Candida albicans biofilm formation. Cell. Microbiol. 8(9), 1382-1391 (2006). (Pubitemid 44194572)
40. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot. Cell 5(10), 1604-1610 (2006). (Pubitemid 44622591)
41. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin. Microbiol. Rev. 17(2), 255-267 (2004). (Pubitemid 38534029)
42. Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis. 21(11), 767-774 (2002). (Pubitemid 35435697)
43. Kumamoto CA. Candida biofilms. Curr. Opin. Microbiol. 5(6), 608-611 (2002). (Pubitemid 35434552)
44. Inglis DO, Arnaud MB, Binkley J et al. The Candida genome database incorporates multiple Candida species: multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic. Acids Res. 40, D667-D674 (2012).
45. Butler G, Rasmussen MD, Lin MF et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459(7247), 657-662 (2009).
46. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr. Opin. Microbiol. 8(4), 378-384 (2005). (Pubitemid 41021896)
47. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit. Rev. Microbiol. 35(4), 340-355 (2009).
48. Martinez LR, Fries BC. Fungal biofilms: relevance in the setting of human disease. Curr. Fungal Infect. Rep. 4(4), 266-275 (2010).
49. Paulitsch AH, Willinger B, Zsalatz B, Stabentheiner E, Marth E, Buzina W. In vivo Candida biofilms in scanning electron microscopy. Med. Mycol. 47(7), 690-696 (2009).
50. Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr. Infect. Dis. J. 24(2), 167-174 (2005). (Pubitemid 40250777)
51. Shin JH, Kee SJ, Shin MG et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J. Clin. Microbiol. 40(4), 1244-1248 (2002). (Pubitemid 34279883)
52. Silva S, Negri M, Henriquez M, Oliveira R, Williams D, Azeredo J. Silicone colonization by non-Candida albicans Candida species in the presence of urine. J. Med. Microbiol. 59(Pt 7), 747-754 (2010).
53. Manzano-Gayosso P, Hernandez-Hernandez F, Zavala-Velasquez N et al. Candiduria in Type 2 diabetes mellitus patients and its clinical significance. Candida spp antifungal susceptibility. Rev. Med. Inst. Mex. Seguro Soc. 46(6), 603-610 (2008).
54. Krcmery S. Urinary tract infections in renal transplant patients. In: Urinary Tract Infections (Volume 1). Bergan T (Ed.). Karger, Basel, Switzerland, 48-52 (1997).
55. Guglielmo BJ, Stoller ML, Jacobs RA. Management of candiduria. Int. J. Antimicrob. Agents 4(2), 135-139 (1994). (Pubitemid 24187407)
56. Junqueira JC, Fuchs BB, Muhammed M et al. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates. BMC Microbiol. 11, 247 (2011).
57. Tumbarello M, Posteraro B, Trecarichi EM et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J. Clin. Microbiol. 45(6), 1843-1850 (2007). (Pubitemid 46933916)
58. Dranginis AM, Rauceo JM, Coronado JE, Lipke PN. A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol. Mol. Biol. Rev. 71(2), 282-294 (2007). (Pubitemid 46954307)
59. Mora-Montes HM, Ponce-Noyola P, Villagomez-Castro JC, Gow NA, Flores-Carreon A, Lopez-Romero E. Protein glycosylation in Candida. Future Microbiol. 4(9), 1167-1183 (2009).
60. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol. 9(4), 340-345 (2006). (Pubitemid 44108718)
61. Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9(6), 588-594 (2006). (Pubitemid 44791986)
62. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46(3), 397-403 (2000).
63. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 11(1), 30-36 (2003). (Pubitemid 36084353)
64. Ganguly S, Bishop AC, Xu W et al. Zap1 control of cell-cell signaling in Candida albicans biofilms. Eukaryot. Cell 10(11), 1448-1454 (2011).
65. Nobile CJ, Nett JE, Hernday AD et al. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol. 7(6), e1000133 (2009).
66. Finkel JS, Xu W, Huang D et al. Portrait of Candida albicans adherence regulators. PLoS Pathog. 8(2), e1002525 (2012).
67. Fidel PL, Jr., Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12(1), 80-96 (1999). (Pubitemid 29055954)
68. Iraqui I, Garcia-Sanchez S, Aubert S et al. The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway. Mol. Microbiol. 55(4), 1259-1271 (2005). (Pubitemid 40299192)
69. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch. Oral Biol. 54(11), 1052-1060 (2009).
70. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62(3), 915-921 (1994). (Pubitemid 24065575)
71. Hogan DA. Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryot. Cell 5(4), 613-619 (2006).
72. Hornby JM, Jensen EC, Lisec AD et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67(7), 2982-2992 (2001). (Pubitemid 33644762)
73. Hornby JM, Nickerson KW. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob. Agents Chemother. 48(6), 2305-2307 (2004). (Pubitemid 38691638)
74. Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191(5), 1393-1403 (2009).
75. Alem MA, Oteef MD, Flowers TH, Douglas LJ. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot. Cell 5(10), 1770-1779 (2006). (Pubitemid 44622603)
76. Cao YY, Cao YB, Xu Z et al. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob. Agents Chemother. 49(2), 584-589 (2005). (Pubitemid 40175666)
77. Weber K, Schulz B, Ruhnke M. The quorum-sensing molecule E,E-farnesol-its variable secretion and its impact on the growth and metabolism of Candida species. Yeast 27(9), 727-739 (2010).
78. el-Azizi M, Khardori N. Factors influencing adherence of Candida spp. to host tissues and plastic surfaces. Indian J. Exp. Biol. 37(10), 941-951 (1999). (Pubitemid 29482157)
79. Harrison JJ, Ceri H, Yerly J et al. Metal ions may suppress or enhance cellular differentiation in Candida albicans and Candida tropicalis biofilms. Appl. Environ. Microbiol. 73(15), 4940-4949 (2007). (Pubitemid 47237243)
80. Monteiro DR, Gorup LF, Silva S et al. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata. Biofouling 27(7), 711-719 (2011).
81. McCourtie J, Douglas LJ. Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect. Immun. 32(3), 1234-1241 (1981). (Pubitemid 11109834)
82. Estivill D, Arias A, Torres-Lana A, Carrillo-Munoz AJ, Arevalo MP. Biofilm formation by five species of Candida on three clinical materials. J. Microbiol. Methods 86(2), 238-242 (2011).
83. Imamura Y, Chandra J, Mukherjee PK et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob. Agents Chemother. 52(1), 171-182 (2008).
84. Ciok-Pater E, Gospodarek E, Prazynska M, Bogiel T. The evaluation of relationship between the origin of Candida sp. and the ability of biofilm formation on surface of different Biomaterials Med. Dosw. Mikrobiol. 61(3), 273-280 (2009).
85. Richard ML, Plaine A. Comprehensive analysis of glycosylphosphatidylinositol-anchored proteins in Candida albicans. Eukaryot. Cell 6(2), 119-133 (2007).
86. Weig M, Jansch L, Gross U, De Koster CG, Klis FM, De Groot PW. Systematic identification in silico of covalently bound cell wall proteins and analysis of protein-polysaccharide linkages of the human pathogen Candida glabrata. Microbiology 150(Pt 10), 3129-3144 (2004). (Pubitemid 39406185)
87. Chaffin WL, Collins B, Marx JN, Cole GT, Morrow KJ Jr. Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant. Infect. Immun. 61(8), 3449-3458 (1993). (Pubitemid 23223438)
88. Kanbe T, Han Y, Redgrave B, Riesselman MH, Cutler JE. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect. Immun. 61(6), 2578-2584 (1993). (Pubitemid 23159253)
89. Li RK, Cutler JE. Chemical definition of an epitope/adhesin molecule on Candida albicans. J. Biol. Chem. 268(24), 18293-18299 (1993). (Pubitemid 23260356)
90. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283(5407), 1535-1538 (1999). (Pubitemid 129503734)
91. Sundstrom P. Adhesins in Candida albicans. Curr. Opin. Microbiol. 2(4), 353-357 (1999). (Pubitemid 29366954)
92. Sundstrom P, Balish E, Allen CM. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J. Infect. Dis. 185(4), 521-530 (2002). (Pubitemid 34142815)
93. Dwivedi P, Thompson A, Xie Z et al. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS One 6(1), e16218 (2011).
94. Rossignol T, Ding C, Guida A, d'Enfert C, Higgins DG, Butler G. Correlation between biofilm formation and the hypoxic response in Candida parapsilosis. Eukaryot. Cell 8(4), 550-559 (2009).
95. Lain A, Elguezabal N, Brena S et al. Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1. BMC Microbiol. 7, 35 (2007).
96. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 9(7), 327-335 (2001). (Pubitemid 32575277)
97. Hoyer LL, Fundyga R, Hecht JE, Kapteyn JC, Klis FM, Arnold J. Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family. Genetics 157(4), 1555-1567 (2001). (Pubitemid 32298825)
98. Gaur NK, Klotz SA. Expression, cloning, and characterization of a Candida albicans gene, ALA1, that confers adherence properties upon Saccharomyces cerevisiae for extracellular matrix proteins. Infect. Immun. 65(12), 5289-5294 (1997). (Pubitemid 27513582)
99. Hoyer LL, Green CB, Oh SH, Zhao X. Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family-a sticky pursuit. Med. Mycol. 46(1), 1-15 (2008). (Pubitemid 351298235)
100. Hoyer LL, Scherer S, Shatzman AR, Livi GP. Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motif. Mol. Microbiol. 15(1), 39-54 (1995).
101. Zhao X, Oh SH, Coleman DA, Hoyer LL. ALS51, a newly discovered gene in the Candida albicans ALS family, created by intergenic recombination: analysis of the gene and protein, and implications for evolution of microbial gene families. FEMS Immunol. Med. Microbiol. 61(3), 245-257 (2011).
102. Hoyer LL, Payne TL, Hecht JE. Identification of Candida albicans ALS2 and ALS4 and localization of als proteins to the fungal cell surface. J. Bacteriol. 180(20), 5334-5343 (1998). (Pubitemid 28471529)
103. Nailis H, Vandenbroucke R, Tilleman K, Deforce D, Nelis H, Coenye T. Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions. Mycopathologia 167(1), 9-17 (2009).
104. O'Connor L, Lahiff S, Casey F, Glennon M, Cormican M, Maher M. Quantification of ALS1 gene expression in Candida albicans biofilms by RT-PCR using hybridisation probes on the LightCycler. Mol. Cell. Probes 19(3), 153-162 (2005). (Pubitemid 40432088)
105. Nobile CJ, Fox EP, Nett JE et al. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148(1-2), 126-138 (2012).
106. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 3(2), 536-545 (2004). (Pubitemid 38497991)
107. Nobile CJ, Schneider HA, Nett JE et al. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol. 18(14), 1017-1024 (2008).
108. Nobile CJ, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr. Biol. 15(12), 1150-1155 (2005). (Pubitemid 40841360)
109. Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, Hoyer LL. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology 150(Pt 2), 267-275 (2004). (Pubitemid 38220029)
110. Yeater KM, Chandra J, Cheng G et al. Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 153(Pt 8), 2373-2385 (2007). (Pubitemid 47262027)
111. Nailis H, Kucharikova S, Ricicova M et al. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and-independent gene expression. BMC Microbiol. 10, 114 (2010).
112. Zhao X, Oh SH, Hoyer LL. Deletion of ALS5, ALS6 or ALS7 increases adhesion of Candida albicans to human vascular endothelial and buccal epithelial cells. Med. Mycol. 45(5), 429-434 (2007). (Pubitemid 47190128)
113. Ding C, Butler G. Development of a gene knockout system in Candida parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot. Cell 6(8), 1310-1319 (2007). (Pubitemid 47257700)
114. Cormack BP, Ghori N, Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285(5427), 578-582 (1999).
115. Castano I, Pan SJ, Zupancic M, Hennequin C, Dujon B, Cormack BP. Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol. Microbiol. 55(4), 1246-1258 (2005). (Pubitemid 40299191)
116. De Las Penas A, Pan SJ, Castano I, Alder J, Cregg R, Cormack BP. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1-and SIR-dependent transcriptional silencing. Genes Dev. 17(18), 2245-2258 (2003). (Pubitemid 37128640)
117. Rosas-Hernandez LL, Juarez-Reyes A, Arroyo-Helguera OE et al. yKu70/yKu80 and Rif1 regulate silencing differentially at telomeres in Candida glabrata. Eukaryot. Cell 7(12), 2168-2178 (2008).
118. Marcet-Houben M, Gabaldon T. The tree versus the forest: the fungal tree of life and the topological diversity within the yeast phylome. PLoS One 4(2), e4357 (2009).
119. Roetzer A, Gabaldon T, Schuller C. From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: important adaptations for an opportunistic pathogen. FEMS Microbiol. Lett. 314(1), 1-9 (2011).
120. Hashash R, Younes S, Bahnan W et al. Characterisation of Pga1, a putative Candida albicans cell wall protein necessary for proper adhesion and biofilm formation. Mycoses 54(6), 491-500 (2011).
121. Laforet L, Moreno I, Sanchez-Fresneda R et al. Pga26 mediates filamentation and biofilm formation and is required for virulence in Candida albicans. FEMS Yeast Res. 11(5), 389-397 (2011).
122. Li F, Palecek SP. Distinct domains of the Candida albicans adhesin Eap1p mediate cell-cell and cell-substrate interactions. Microbiology 154(Pt 4), 1193-1203 (2008). (Pubitemid 351736276)
123. Li F, Svarovsky MJ, Karlsson AJ et al. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Eukaryot. Cell 6(6), 931-939 (2007). (Pubitemid 46983293)
124. Moreno-Ruiz E, Ortu G, de Groot PW et al. The GPI-modified proteins Pga59 and Pga62 of Candida albicans are required for cell wall integrity. Microbiology 155(Pt 6), 2004-2020 (2009).
125. Li F, Palecek SP. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot. Cell 2(6), 1266-1273 (2003). (Pubitemid 38047235)
126. Hayek P, Dib L, Yazbeck P, Beyrouthy B, Khalaf RA. Characterization of Hwp2, a Candida albicans putative GPI-anchored cell wall protein necessary for invasive growth. Microbiol. Res. 165(3), 250-258 (2010).
127. Ene IV, Bennett RJ. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot. Cell 8(12), 1909-1913 (2009).
128. Younes S, Bahnan W, Dimassi HI, Khalaf RA. The Candida albicans Hwp2 is necessary for proper adhesion, biofilm formation and oxidative stress tolerance. Microbiol. Res. 166(5), 430-436 (2011).
129. Daher JY, Koussa J, Younes S, Khalaf RA. The Candida albicans Dse1 protein is essential and plays a role in cell wall rigidity, biofilm formation, and virulence. Interdiscip. Perspect. Infect. Dis. 2011, 504280 (2011).
130. Kelly MT, MacCallum DM, Clancy SD, Odds FC, Brown AJ, Butler G. The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol. Microbiol. 53(3), 969-983 (2004). (Pubitemid 39036973)
131. Sandini S, La Valle R, De Bernardis F, Macri C, Cassone A. The 65 kDa mannoprotein gene of Candida albicans encodes a putative beta-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity. Cell. Microbiol. 9(5), 1223-1238 (2007). (Pubitemid 46547140)
132. Sandini S, Stringaro A, Arancia S. The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans. BMC Microbiol. 11, 106 (2011).
133. Hiller E, Heine S, Brunner H, Rupp S. Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, and biofilm formation. Eukaryot. Cell 6(11), 2056-2065 (2007). (Pubitemid 350221274)
134. Norice CT, Smith FJ Jr, Solis N, Filler SG, Mitchell AP. Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot. Cell 6(11), 2046-2055 (2007). (Pubitemid 350221273)
135. Bernardo SM, Lee SA. Candida albicans SUR7 contributes to secretion, biofilm formation, and macrophage killing. BMC Microbiol. 10, 133 (2010).
136. de Groot PW, Kraneveld EA, Yin QY et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot. Cell 7(11), 1951-1964 (2008).
137. Zupancic ML, Frieman M, Smith D, Alvarez RA, Cummings RD, Cormack BP. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol. Microbiol. 68(3), 547-559 (2008). (Pubitemid 351490190)
138. Kraneveld EA, de Soet JJ, Deng DM et al. Identification and differential gene expression of adhesin-like wall proteins in Candida glabrata biofilms. Mycopathologia 172(6), 415-427 (2011).
139. Damke E, Storti-Filho A, Irie MM et al. Ultrastructural imaging of Candida albicans adhesion to rat genital epithelium through scanning and transmission electron microscopy. Microsc. Microanal. 16(3), 337-345 (2010).
140. Lattif AA, Mukherjee PK, Chandra J et al. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int. J. Med. Microbiol. 300(4), 265-270 (2010).
141. Paiva LC, Vidigal PG, Donatti L, Svidzinski TI, Consolaro ME. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics. Micron 43(2-3), 497-502 (2012).
142. Dostal J, Brynda J, Hruskova-Heidingsfeldova O, Sieglova I, Pichova I, Rezacova P. The crystal structure of the secreted aspartic protease 1 from Candida parapsilosis in complex with pepstatin A. J. Struct. Biol. 167(2), 145-152 (2009).
143. Blewett P. Radiation losses in the induction electron accelerator. Phys. Rev. 69(3-4), 87-95 (1946).
144. Schwinger J. Electron radiation in high energy accelerators. Phys. Rev. 70, 798-799 (1946).
145. Schwinger J. On the classical radiation of accelerated electrons. Phys. Rev. 75, 1912-1925 (1949).
146. Edirisinghe PD, Moore JF, Skinner-Nemec KA et al. Detection of in situ derivatized peptides in microbial biofilms by laser desorption 7.87 eV postionizaton mass spectrometry. Anal. Chem. 79(2), 508-514 (2007). (Pubitemid 46106114)
147. Akhmetov A, Moore JF, Gasper GL, Koin PJ, Hanley L. Laser desorption postionization for imaging MS of biological material. J. Mass Spectrom. 45(2), 137-145 (2010).
148. Barbosa RL, Rinaldi FC, Guimaraes BG, Benedetti CE. Crystallization and preliminary x-ray analysis of BigR, a transcription repressor from Xylella fastidiosa involved in biofilm formation. Acta Crystallogr. Sect. F Struct. Biol. Crys. Commun. 63(Pt 7), 596-598 (2007). (Pubitemid 47052210)
149. Gasper GL, Takahashi LK, Zhou J, Ahmed M, Moore JF, Hanley L. Laser desorption postionization mass spectrometry of antibiotic-treated bacterial biofilms using tunable vacuum ultraviolet radiation. Anal. Chem. 82(17), 7472-7478 (2010).
150. Hanley L, Zimmermann R. Light and molecular ions: the emergence of vacuum UV single-photon ionization in MS. Anal. Chem. 81(11), 4174-4182 (2009).
151. Garcia-Gutierrez MC, Rueda DR. Bases of synchrotron radiation, light sources, and features of x-ray scattering beamlines. In: Applications of Synchrotron Light to Scattering and Diffraction in Materials and Life Sciences (Volume 776). Esquerra TA, García-Gutiérrez MC, Nogales A, Gómez MA (Eds). Springer Verlag, Heidelberg, Germany, 1-22 (2009).
152. Golan A, Bravaya KB, Kudirka R et al. Ionization of dimethyluracil dimers leads to facile proton transfer in the absence of hydrogen bonds. Nat. Chem. 4(4), 323-329 (2012).
153. Gilbert NM, Baker LG, Specht CA, Lodge JK. A glycosylphosphatidylinositol anchor is required for membrane localization but dispensable for cell wall association of chitin deacetylase 2 in Cryptococcus neoformans. MBio. 3(1), e00007-e000012 (2012).
154. Martinez LR, Ibom DC, Casadevall A, Fries BC. Characterization of phenotypic switching in Cryptococcus neoformans biofilms. Mycopathologia 166(4), 175-180 (2008).
155. Ravi S, Pierce C, Witt C, Wormley FL Jr. Biofilm formation by Cryptococcus neoformans under distinct environmental conditions. Mycopathologia 167(6), 307-314 (2009).
156. Martinez LR, Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect. Immun. 73(10), 6350-6362 (2005). (Pubitemid 41368796)
157. Walsh TJ, Schlegel R, Moody MM, Costerton JW, Salcman M. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 18(3), 373-375 (1986). (Pubitemid 16139400)
158. Banerjee U, Gupta K, Venugopal P. A case of prosthetic valve endocarditis caused by Cryptococcus neoformans var. neoformans. J. Med. Vet. Mycol. 35(2), 139-141 (1997). (Pubitemid 27174587)
159. Braun DK, Janssen DA, Marcus JR, Kauffman CA. Cryptococcal infection of a prosthetic dialysis fistula. Am. J. Kidney Dis. 24(5), 864-867 (1994). (Pubitemid 24350476)
160. Martinez LR, Mihu MR, Han G et al. The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials 31(4), 669-679 (2010).
161. Martinez LR, Casadevall A. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 50(3), 1021-1033 (2006). (Pubitemid 43327808)
162. Krzossok S, Birck R, Henke S, Hof H, van der Woude FJ, Braun C. Trichosporon asahii infection of a dialysis PTFE arteriovenous graft. Clin. Nephrol. 62(1), 66-68 (2004). (Pubitemid 38979112)
163. Pini G, Faggi E, Donato R, Fanci R. Isolation of Trichosporon in a hematology ward. Mycoses 48(1), 45-49 (2005). (Pubitemid 40255401)
164. Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob. Agents Chemother. 50(10), 3269-3276 (2006). (Pubitemid 44527497)
165. Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C. Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol. Lett. 324(2), 89-97 (2011).
166. Langer P, Kassim RA, Macari GS, Saleh KJ. Aspergillus infection after total knee arthroplasty. Am. J. Orthop. 32(8), 402-404 (2003).
167. Escande W, Fayad G, Modine T et al. Culture of a prosthetic valve excised for streptococcal endocarditis positive for Aspergillus fumigatus 20 years after previous a fumigatus endocarditis. Ann. Thorac. Surg. 91(6), e92-e93 (2011).
168. Jeloka TK, Shrividya S, Wagholikar G. Catheter outflow obstruction due to an aspergilloma. Perit. Dial. Int. 31(2), 211-212 (2011).
169. Beauvais A, Schmidt C, Guadagnini S et al. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell. Microbiol. 9(6), 1588-1600 (2007). (Pubitemid 46774028)
170. Seidler MJ, Salvenmoser S, Muller FM. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob. Agents Chemother. 52(11), 4130-4136 (2008).
171. Scholtmeijer K, Wessels JGH, Woster HAB. Fungal hydrophobins in medical and technical applications. Appl. Microbiol. Biotechnol. 56(1-2), 1-8 (2001). (Pubitemid 32661535)
172. Wosten HAB. Hydrophobins: multipurpose proteins. Annu. Rev. Microbiol. 55, 625-646 (2001). (Pubitemid 32978118)
173. Linder MB, Szilvay GR, Nakari-Setala T, Penttila ME. Hydrophobins: the protein-amphiphiles of filamentous fungi. FEMS Microbiol. Rev. 29(5), 877-896 (2005). (Pubitemid 41416842)
174. Bruns S, Seidler M, Albrecht D et al. Functional genomic profiling of Aspergillus fumigatus biofilm reveals enhanced production of the mycotoxin gliotoxin. Proteomics 10(17), 3097-3107 (2010).
175. Perez A, Ramage G, Blanes R, Murgui A, Casanova M, Martinez JP. Some biological features of Candida albicans mutants for genes coding fungal proteins containing the CFEM domain. FEMS Yeast Res. 11(3), 273-284 (2011).